Mindray Debuts High-end Ventilator SV800 in Vienna

Food and Healthcare Press Releases Monday September 25, 2017 15:02
SHENZHEN, China--25 Sep--PRNewswire/InfoQuest
Mindray announced that its new-generation ventilator SV800 has been officially released. The new ventilator was showcased for the first time at the ESICM 2017 held in Vienna.

The SV800, as a high-end ventilator featured with a 1080P HD wide screen, combines an intuitive customized UI with powerful assistive tools and modules. The SV800 enables clinicians to make life supporting much more easily and enjoy the unprecedented operational freedom, decision-making freedom and connecting freedom in the hectic clinical environment.

"The SV800 is designed to fill the gap of the high-end critical care market. Mindray spent five years forging such a product with intelligent functions and original designs. It's a perfect combination of clinical experts' wisdom and Mindray's industrial wisdom," said Mr. Yan Yongsheng, director of Mindray's ventilators and anesthesia products.

The SV800 provides users a 360-degree clear view and a flat-style UI which can be customized according to users' habitual operations. Besides the superb screen and UI design, the SV800 brings operational freedom for clinicians with powerful functions such as the intuitive dynamic PulmoSight™ and graphical guidelines, which help clinicians quickly know the ventilation state and improve the operational efficiency.

With optional treatment modes and powerful assistive tools, the SV800 creates decision-making freedom, helping clinicians to make clinical decisions with composure. Intelligent modes including AMV™+IntelliCycle™ and CPRV™ facilitate clinicians to deal with daily challenges. The SV800 also has enhanced features including Dual-channel Auxiliary Pressure Measurement and Weaning Assistive Tool.

As an innovative and intelligent high-end ventilator, the SV800 can also bring users connecting freedom with diversified modules including Built-in Neonatal Module, SpO2 Module and C600 Back-up Air Supply. Furthermore, the SV800 can be connected to the hospital information system.

For many years, Mindray has been in pursuit of innovative technologies in ventilators field. Users can experience the cutting-edge medical technologies with this new ventilator. The SV800 elevates users' experience to a brand-new level and witnesses Mindray's endeavor of climbing peaks of technology. Mindray will keep advancing medical technologies to make healthcare more accessible.

About Mindray:

Mindray is a leading global developer of medical devices and solutions, dedicated to making better healthcare more accessible to humanity. Since its foundation in 1991, Mindray has been exclusively focused on the medical industry in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging.

Photo - https://photos.prnasia.com/prnh/20170925/1949271-1
Caption: The new generation ventilator SV800

Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics